Eikonoklastes

Overview

Cincinnati-based biopharmaceutical company founded in 2019, developing immunotherapies for neurodegenerative diseases (including ALS) and triple-negative breast cancer; backed by Rev1 Ventures, CincyTech and JobsOhio Ventures.

Key Facts

Sector

Biopharmaceuticals

Focus Areas